BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Fireballs and a full moon. Here’s how to see two celestial events this week - 2Emotional wellness Matters: My Fight with Tension
- 3Defense Minister Katz moves to extend IDF service to 36 months
- 4The largest sun of 2026 rises today as Earth draws closest to our parent star
- 5A company is trying to unlock a key to aging, in a long-overlooked body part
- Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- NASA's Artemis 2 pilot Victor Glover listens to 'Whitey on the Moon' every Monday. This is why.
- One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- Shredded cheese recall: Multiple brands sold at Aldi, Target and Walmart affected over potential metal fragment contamination
- Must-See Attractions in Washington, D.C.
- Consumers advised to dispose of 19 cooking pans due to lead leaching risk, FDA reports
- Drones haven't won the fight in Ukraine. That matters as the West learns new ways of war.
